Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available. -
Recent studies suggest the weight loss and diabetes drugs may prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer. -
There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.
-
A new drug for pancreatic cancer gives some hope for one of the most dire types of cancer.
-
The American Cancer Society is changing its screening recommendations for colorectal cancer, suggesting adults begin screening at age 45 and adding blood-based tests as an option.
-
Although pancreatic cancer remains very lethal, a few new kinds of therapies are coming
-
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before. -
It's a very treatable form of cancer if caught early, yet younger adults rarely get screened. Patient advocates want more people to talk to their doctors about risk factors and number two. -
Unlike many cancers, colorectal cancer has become more lethal for people at younger ages. Doctors are sleuthing out why.
-
Unlike many cancers, colorectal cancer has become more lethal for people at younger ages. Doctors are sleuthing out why.
